Researcher
Martijn Risseeuw
- Disciplines:Medicinal chemistry, Pharmacognosy and phytochemistry, Pharmaceutics, Biomarker discovery and evaluation, Other pharmaceutical sciences, Toxicology and toxinology, Pharmacotherapy, Pharmacology, Small molecules, Clinical trials
Affiliations
- Department of Pharmaceutics (Department)
Member
From1 Jan 2010 → Today
Projects
1 - 1 of 1
- Expedient purification of bioactive small molecules and/or their PEG conjugates using automated preparative HPLCFrom1 Jun 2015 → 31 May 2017Funding: BOF - Other initiatives
Publications
1 - 10 of 69
- Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents(2023)
Authors: Charlotte Courtens, Frits van Charante, Thibaut Quennesson, Martijn Risseeuw, Paul Cos, Guy Caljon, Tom Coenye, Serge Van Calenbergh
- Targeted AURKA degradation : towards new therapeutic agents for neuroblastoma(2023)
Authors: Muhammad Rishfi, Simon Krols, Fien Martens, Sarah-Lee Bekaert, Aline Eggermont, Fanny De Vloed, Joshua Robert Goulding, Martijn Risseeuw, Jan Molenaar
- Report on a new opioid NPS : chemical and in vitro functional characterization of a structural isomer of the MT-45 derivative diphenpipenol(2021)
Authors: Annelies Cannaert, Fabian Hulpia, Martijn Risseeuw, Katleen Van Uytfanghe, Eric Deconinck, Peter Blanckaert
Pages: 134 - 140 - 2-((3,5-Dinitrobenzyl)thio)quinazolinones : potent antimycobacterial agents activated by deazaflavin (F420)-dependent nitroreductase (Ddn)(2021)
Authors: Yanlin Jian, He Eun Forbes, Fabian Hulpia, Martijn Risseeuw, Guy Caljon, Hélène Munier-Lehmann, Helena I. M. Boshoff
Pages: 440 - 457 - RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia(2021)
Authors: Filip Matthijssens, Nitesh D. Sharma, Monique Nysus, Christian K. Nickl, Huining Kang, Dominique R. Perez, Wouter Van Loocke, Sofie Peirs, Lindy Reunes, Filip Van Nieuwerburgh, et al.
- Structure-aided optimization of non-nucleoside M. tuberculosis thymidylate kinase inhibitors(2021)
Authors: Lijun Song, Romain Merceron, Fabian Hulpia, Ainhoa Lucia, Begona Gracia, Yanlin Jian, Martijn Risseeuw, Toon Verstraelen, Paul Cos, Jose A. Ainsa, et al.
- Synthetic rhamnose glycopolymer cell-surface receptor for endogenous antibody recruitment(2020)
Authors: Ruben De Coen, Lutz Nuhn, Chamani Perera, Maria Arista-Romero, Martijn Risseeuw, Alec Freyn, Raffael Nachbagauer, Lorenzo Albertazzi, David A. Spiegel, Blake R. Peterson, et al.
Pages: 793 - 802 - Endeavors towards transformation of M. tuberculosis thymidylate kinase (MtbTMPK) inhibitors into potential antimycobacterial agents(2020)
Authors: Yanlin Jian, Romain Merceron, Steven De Munck, He Eun Forbes, Fabian Hulpia, Martijn Risseeuw, Kristof Van Hecke, Savvas Savvides, Hélène Munier-Lehmann, Helena I. M. Boshoff
- Synthesis and structure activity relationships of cyanopyridone based anti-tuberculosis agents(2020)
Authors: Yanlin Jian, Fabian Hulpia, Martijn Risseeuw, He Eun Forbes, Hélène Munier-Lehmann, Guy Caljon, Helena I. M. Boshoff, Serge Van Calenbergh
- 1-(1-Arylethylpiperidin-4-yl)thymine analogs as antimycobacterial TMPK inhibitors(2020)
Authors: Yanlin Jian, Fabian Hulpia, Martijn Risseeuw, He Eun Forbes, Guy Caljon, Hélène Munier-Lehmann, Helena I. M. Boshoff, Serge Van Calenbergh
Patents
1 - 3 of 3
- HAMAMELITANNIN ANALOGUES AND USES THEREOF (Inventor)
- HAMAMELITANNIN ANALOGUES AND USES THEREOF (Inventor)
- NOVEL HAMAMELITANNIN ANALOGUES AND USES THEREOF (Inventor)